Tag:
IPO
Latest Headlines
Latest Headlines
Cancer Genetics' IPO delayed amid Facebook frenzy
Seeking Alpha reasoned this week that Cancer Genetics' IPO might be small enough to slip through even though Wall Street has been bracing for the blockbuster maiden offering of Facebook. Guess not.
Merrimack Pharma stumbles out of the IPO gate
Merrimack's shares fell 13.7% from the opening price of $7 per share, giving the developer of cancer drugs a lackluster public debut.
Merrimack Pharma discounts expectations in $100M IPO
Merrimack Pharmaceuticals , a Cambridge, MA-based developer with 5 cancer therapies in the pipeline, is hoping that it can finally pull off an IPO.
Long-awaited biotech IPOs on horizon in land of Novartis and Roche?
There have been few biotech IPOs in both the U.S. and Europe in recent years, yet the drought of maiden public offerings has lasted four long years in biotech-rich Switzerland. However, industry
Ambit bounces back from dropped IPO with $30M round
A day after word that Ambit Biosciences had dropped plans for an $86 million IPO, venture investors have swooped in and replenished the cancer drug developer's coffers with a $30 million equity
